glutamine has been researched along with Coronary Restenosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asada, Y; Gi, T; Kitamura, K; Koyama, S; Maekawa, K; Matsuura, Y; Saito, Y; Yamashita, A | 1 |
1 other study(ies) available for glutamine and Coronary Restenosis
| Article | Year |
|---|---|
Intracellular glutamine level determines vascular smooth muscle cell-derived thrombogenicity.
Topics: Animals; Cardiovascular Agents; Coronary Restenosis; Drug-Eluting Stents; Glutamine; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Percutaneous Coronary Intervention; Prosthesis Design; Rabbits | 2021 |